The FDA approved Ojjaara for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in ...

GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l'assurance maladie du Québec ...

In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses treatment options for chronic kidney disease patients with ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...

Anemia, a deficiency in healthy red blood cells, can affect the appearance of the eyes and eyelids. It can also cause eye ...

The new treatment is painful and expensive. It could also be life-saving. If you can't access your feeds, please contact customer support. Thanks! Check your phone ...

MARION COUNTY, Miss. (WDAM) - A Columbia mom and son have prepared for a rare procedure, hoping it will cure sickle cell anemia. Throughout 10-year-old Taylor Allen’s sickle cell journey, Taylor has ...

TALLAHASSEE, Fla. (WCTV) - Sickle Cell Anemia is a rare disease without a cure. The people sickle cell anemia affects are more than 90% African American or non-Hispanic Black. September is Sickle Cell ...

The 2025 NCAA Outdoor Track and Field Championship came to a close on Saturday with Georgia securing the women’s national title. Sixteen... University biologist and neuroscientist John Postlethwait ...